News in brief: TGA ponders rule change; no repeal of German law; Argent signs Malta deal; new role for Kylie O’Brien by Steve Jones April 10, 2025April 10, 2025 The Therapeutic Goods Administration (TGA) is reviewing the Special Access Scheme timeframes around the approval of […]
News in brief: Rua’s German stock shortage; Zelira’s finance deal; cultivator nets $1.4m; Neurotech exec steps down; ‘major milestone’ for Argent; Cann Group pharmacy deal by Steve Jones and Martin Lane April 3, 2025April 3, 2025
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
Poor share trading and lack of interest in capital raise sees Argent seek delisting from ASX by Steve Jones August 15, 2024August 15, 2024
Company news: Zelira Therapeutics; Ecofibre; Cann Group; InhaleRx; Argent Biopharma; Melodiol Global Health; Wellnex Life by Steve Jones July 4, 2024November 25, 2024
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma by Martin Lane and Steve Jones April 16, 2024July 16, 2024
